Chronic lymphocytic leukemia with essential thrombocythemia: asbestos exposure association?
暂无分享,去创建一个
[1] N. Cross. Genetic and epigenetic complexity in myeloproliferative neoplasms. , 2011, Hematology. American Society of Hematology. Education Program.
[2] R. Foà,et al. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience , 2011, American journal of hematology.
[3] G. Marti,et al. Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas. , 2010, European journal of clinical & medical oncology.
[4] S. Stilgenbauer,et al. Immunoglobulin Heavy Chain Variable Gene Usage and (Super)-antigen Drive in Chronic Lymphocytic Leukemia , 2010, Clinical Cancer Research.
[5] D. Palli,et al. Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms , 2009, Cancer Epidemiology Biomarkers & Prevention.
[6] Ashot Harutyunyan,et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms , 2009, Nature Genetics.
[7] Axel Benner,et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival , 2007, Haematologica.
[8] Stefan N. Constantinescu,et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.